onr:"swepub:oai:prod.swepub.kib.ki.se:131199191"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:131199191" > A PHASE 2B, 24-WEEK...
- 1 of 1
- Previous record
- Next record
- To hitlist
A PHASE 2B, 24-WEEK STUDY OF VX-509 (DECERNOTINIB), AN ORAL SELECTIVE JANUS KINASE 3 INHIBITOR, IN COMBINATION WITH BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS
- van Vollenhoven, R (author)
- Genovese, MC (author)
- Zhang, Y (author)
- show more...
- Kinnman, N (author)
- show less...
- 2014-06-10
- 2014
- English.
- In: ANNALS OF THE RHEUMATIC DISEASES. - : BMJ. - 0003-4967 .- 1468-2060. ; 73, s. 118-118
- Conference paper (other academic/artistic)
Subject headings
Close
Publication and Content Type
- vet (subject category)
- kon (subject category)
Find in a library
- ANNALS OF THE RHEUMATIC DISEASES (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- van Vollenhoven, ...
- Genovese, MC
- Zhang, Y
- Kinnman, N
- Articles in the publication
- ANNALS OF THE RH ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
